R3 Asset Management Pte

Axonis Therapeutics is a biotechnology company focused on developing therapies for neurological disorders by targeting KCC2, a key mediator of inhibition in the brain. The company utilizes a proprietary discovery engine centered on the neuron-specific K-Cl cotransporter (KCC2) to address various conditions, including epilepsy and pain, as well as other central nervous system pathologies. By harnessing breakthrough research from institutions such as Boston Children’s Hospital, Harvard, and Laval University, Axonis aims to enhance the lives of individuals affected by these disorders through improved modulation of neuronal inhibition.

Vividthree Productions Pte. Ltd. is a prominent company based in Singapore that specializes in motion picture post-production, visual effects (VFX), and 3D animation. Founded in 2004, the company has established itself as a leading studio in the realms of multimedia and interactive design, offering services that include three-dimensional animation and computer-generated imagery (CGI). It has developed a strong reputation and network presence in Singapore, Malaysia, and China, positioning itself as a go-to studio for immersive digital content production. Vividthree Productions operates as a subsidiary of mm2 Entertainment Pte. Ltd. and continues to contribute significantly to the visual effects and animation industries in the region.